PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,140,742 | -44.9% | 7,235,196 | 0.0% | 3.42% | -38.9% |
| Q2 2023 | $294,255,421 | -14.4% | 7,235,196 | +2.0% | 5.60% | -21.7% |
| Q1 2023 | $343,599,355 | +60.3% | 7,093,298 | +26.3% | 7.16% | +63.5% |
| Q4 2022 | $214,339,322 | -24.0% | 5,615,387 | -0.1% | 4.38% | -32.7% |
| Q3 2022 | $282,153,000 | +39.6% | 5,620,580 | +11.4% | 6.50% | +24.6% |
| Q2 2022 | $202,115,000 | +3.8% | 5,045,307 | -3.4% | 5.22% | +29.5% |
| Q1 2022 | $194,804,000 | -7.6% | 5,221,228 | -1.4% | 4.03% | +31.0% |
| Q4 2021 | $210,859,000 | +7.0% | 5,293,966 | 0.0% | 3.08% | +3.6% |
| Q3 2021 | $196,988,000 | -12.0% | 5,293,966 | 0.0% | 2.97% | -12.0% |
| Q2 2021 | $223,776,000 | -10.7% | 5,293,966 | 0.0% | 3.38% | -13.7% |
| Q1 2021 | $250,669,000 | -2.7% | 5,293,966 | +25.4% | 3.91% | -9.5% |
| Q4 2020 | $257,659,000 | +38.0% | 4,221,836 | +5.7% | 4.32% | -3.8% |
| Q3 2020 | $186,686,000 | -7.2% | 3,993,286 | +0.8% | 4.50% | -20.5% |
| Q2 2020 | $201,089,000 | +14.6% | 3,963,120 | +0.8% | 5.66% | -25.1% |
| Q1 2020 | $175,440,000 | -4.7% | 3,932,746 | +2.6% | 7.55% | +8.7% |
| Q4 2019 | $184,074,000 | +49.1% | 3,832,480 | +5.0% | 6.94% | -5.4% |
| Q3 2019 | $123,489,000 | -12.5% | 3,651,361 | +16.4% | 7.34% | -2.6% |
| Q2 2019 | $141,181,000 | +49.2% | 3,137,361 | +24.8% | 7.54% | +16.7% |
| Q1 2019 | $94,637,000 | +43.4% | 2,514,271 | +30.8% | 6.46% | +5.2% |
| Q4 2018 | $65,975,000 | -57.1% | 1,922,346 | -41.3% | 6.14% | -33.4% |
| Q3 2018 | $153,953,000 | +12.0% | 3,275,591 | -19.6% | 9.22% | -7.0% |
| Q2 2018 | $137,406,000 | +22.7% | 4,073,690 | -1.6% | 9.91% | -7.0% |
| Q1 2018 | $111,973,000 | +62.5% | 4,137,960 | +0.2% | 10.66% | -7.3% |
| Q4 2017 | $68,890,000 | -1.5% | 4,130,115 | +18.2% | 11.50% | -5.6% |
| Q3 2017 | $69,938,000 | +15.5% | 3,495,143 | +5.8% | 12.18% | -4.6% |
| Q2 2017 | $60,566,000 | +371.4% | 3,304,214 | +153.1% | 12.77% | +277.5% |
| Q1 2017 | $12,848,000 | +18.1% | 1,305,643 | +30.9% | 3.38% | -17.4% |
| Q4 2016 | $10,879,000 | – | 997,166 | – | 4.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |